KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Short term Debt (2016 - 2025)

Eli Lilly's Short term Debt history spans 17 years, with the latest figure at $1.6 billion for Q4 2025.

  • For Q4 2025, Short term Debt fell 68.05% year-over-year to $1.6 billion; the TTM value through Dec 2025 reached $1.6 billion, down 68.05%, while the annual FY2025 figure was $1.6 billion, 68.05% down from the prior year.
  • Short term Debt reached $1.6 billion in Q4 2025 per LLY's latest filing, roughly flat from $1.6 billion in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $6.9 billion in Q4 2023 to a low of $3.1 million in Q1 2023.
  • Average Short term Debt over 5 years is $2.4 billion, with a median of $1.7 billion recorded in 2022.
  • Peak YoY movement for Short term Debt: crashed 99.85% in 2021, then soared 53174.19% in 2024.
  • A 5-year view of Short term Debt shows it stood at $1.5 billion in 2021, then dropped by 2.42% to $1.5 billion in 2022, then skyrocketed by 359.96% to $6.9 billion in 2023, then dropped by 25.89% to $5.1 billion in 2024, then tumbled by 68.05% to $1.6 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Short term Debt are $1.6 billion (Q4 2025), $1.6 billion (Q3 2025), and $5.7 billion (Q2 2025).